ILIAS Biologics Inc. demonstrated the therapeutic effect of anti-inflammatory exosomes for ischemia-reperfusion-induced acute kidney injury
Retrieved on:
Monday, June 28, 2021
It is characterized as a rapid decline in kidney function,and multiple conditions such as acute tubular necrosis and interstitial nephritiscan cause AKI.
Key Points:
- It is characterized as a rapid decline in kidney function,and multiple conditions such as acute tubular necrosis and interstitial nephritiscan cause AKI.
- "Therapeutic exosomes with EXPLOR technology have successfully demonstrated itstherapeutic potential in preclinical models representing multipledisease settings, including sepsis, preterm birth, and AKI.
- Acute Kidney Injury (AKI) is defined as a rapid dysfunction in kidney function and structure, which results from secondary injury caused by multiple conditions such as acute tubular necrosis, glomerulonephritis, vasculitis, ischemia, and drug-induced nephrotoxicity.
- [i]Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group (2012) KDIGO clinical practice guideline for acute kidney injury.